270 related articles for article (PubMed ID: 18418922)
1. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
Makarchuk PA
Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922
[No Abstract] [Full Text] [Related]
2. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics).
Khalif IL; Quigley EM; Makarchuk PA; Golovenko OV; Podmarenkova LF; Dzhanayev YA
J Gastrointestin Liver Dis; 2009 Mar; 18(1):17-22. PubMed ID: 19337628
[TBL] [Abstract][Full Text] [Related]
3. Visceral sensation and irritable bowel syndrome; with special reference to comparison with functional abdominal pain syndrome.
Nozu T; Okumura T
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():122-7. PubMed ID: 21443724
[TBL] [Abstract][Full Text] [Related]
4. Visceral hypersensitivity: fact or fiction.
Aziz Q
Gastroenterology; 2006 Aug; 131(2):661-4. PubMed ID: 16890617
[No Abstract] [Full Text] [Related]
5. Visceral hyperalgesia in children with functional abdominal pain.
Di Lorenzo C; Youssef NN; Sigurdsson L; Scharff L; Griffiths J; Wald A
J Pediatr; 2001 Dec; 139(6):838-43. PubMed ID: 11743510
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of two antispasmodic products: Buscopan and NO-Spa.
Maitai CK; Njoroge DK; Munenge RW
East Afr Med J; 1985 Jul; 62(7):480-5. PubMed ID: 4076027
[No Abstract] [Full Text] [Related]
7. [Progress in role of estrogens in visceral hypersensitivity of IBS].
Dong X; Chen SL
Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):362-4. PubMed ID: 21416927
[No Abstract] [Full Text] [Related]
8. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
[TBL] [Abstract][Full Text] [Related]
9. [Intestinal motility disorders and visceral hypersensitivity in irritable bowel syndrome].
Ropert A; Bouguen G
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S35-9. PubMed ID: 19303537
[TBL] [Abstract][Full Text] [Related]
10. [Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].
Makarchuk PA; Golovenko OV; Mikhaĭlova TL; Podmarenkova LF
Eksp Klin Gastroenterol; 2005; (1):25-9. PubMed ID: 15991849
[No Abstract] [Full Text] [Related]
11. [Meteospazmil for correction of motor disorders in functional colon diseases].
Agafonova NA; Iakovenko EP; Ivanov AN; Prianishnikova AS; Iakovenko AV
Eksp Klin Gastroenterol; 2009; (4):101-6. PubMed ID: 19961001
[TBL] [Abstract][Full Text] [Related]
12. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
[TBL] [Abstract][Full Text] [Related]
13. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
Tack J
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients.
Klooker TK; Leliefeld KE; Van Den Wijngaard RM; Boeckxstaens GE
Neurogastroenterol Motil; 2011 Jan; 23(1):30-5, e2. PubMed ID: 20718944
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE
Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764
[TBL] [Abstract][Full Text] [Related]
19. Testing the sequential model of pain processing in irritable bowel syndrome: a structural equation modeling analysis.
Lackner JM; Jaccard J; Blanchard EB
Eur J Pain; 2005 Apr; 9(2):207-18. PubMed ID: 15737813
[TBL] [Abstract][Full Text] [Related]
20. Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome.
Thoua NM; Murray CD; Winchester WJ; Roy AJ; Pitcher MC; Kamm MA; Emmanuel AV
Aliment Pharmacol Ther; 2009 Mar; 29(5):552-60. PubMed ID: 19076934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
